Castle Biosciences, Inc. (CSTL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 12:13PM EST. Market open.
| Previous close | 35.56 |
| Open | 35.35 |
| Bid | 36.63 x 800 |
| Ask | 37.02 x 800 |
| Day's range | 34.58 - 37.21 |
| 52-week range | 31.46 - 107.69 |
| Volume | |
| Avg. volume | 255,033 |
| Market cap | 936.997M |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.24 |
| Earnings date | 07 Mar 2022 - 11 Mar 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 81.29 |
- Business Wire
Castle Biosciences to Present Data at Maui Derm for Dermatologists 2022
FRIENDSWOOD, Texas, January 24, 2022--Castle Biosciences will present data highlighting its portfolio of skin cancer tests at Maui Derm for Dermatologists 2022, Jan. 24-28, 2022.
- Business Wire
Recently Published Data Confirm DecisionDx®-SCC as a Significant and Independent Risk-Stratification Tool in Patients with Squamous Cell Carcinoma and One or More Risk Factors
FRIENDSWOOD, Texas, January 13, 2022--Castle announced the publication of clinical performance study data related to DecisionDx®-SCC in Future Oncology.
- Business Wire
Data Published in Ocular Oncology and Pathology Demonstrates Highly Accurate Performance of DecisionDx®-UMSeq for Patients with Uveal Melanoma
FRIENDSWOOD, Texas, January 12, 2022--Castle announced the publication of a study in Ocular Oncology and Pathology related to the Company's DecisionDx®-UMSeq 7-gene DNA sequencing panel.
© 2022 Yahoo. All rights reserved.
